EUVIMEDEUVIMED entdecken
Crossref

Treatment of hepatocellular carcinoma with a portal vein tumor thrombus and pulmonary metastases of rectal cancer with microsatellite stability using atezolizumab plus bevacizumab

Yoshitaka Inaba, Shohei Chatani, Shinichi Murata, Yozo Sato, Rinpei Imamine, Mina Kato, Hiroaki Onaya, Hidekazu Yamaura

Clinical Journal of Gastroenterology · 2024

DOI: 10.1007/s12328-024-01921-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Journal of Gastroenterology, 2024. Verfasst von Yoshitaka Inaba und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Interventional Radiology, Aichi Cancer Center Hospital, 1-1, Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan. 1058…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Chemoembolization, Therapeutic, Liver Neoplasms, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herein, we report the successful treatment using atezolizumab plus bevacizumab of a patient with hepatocellular carcinoma (HCC) with a portal vein tumor thrombus and multiple pulmonary metastases from rectal cancer with microsatellite stability. This patient developed rectal cancer with synchronous pulmonary metastases and HCC. After resecting the primary lesion of the rectal cancer, transcatheter arterial chemoembolization was performed for the HCC. Drug therapy was planned for multiple pulmonary metastases of rectal cancer; however, the early development of recurrent HCC with portal vein tumor thrombus had to be highly prioritized, and atezolizumab plus bevacizumab was introduced. Following the disappearance of the recurrent HCC lesion, the metastatic pulmonary nodules shrunk into scar-like spots. The treatment for both HCC and pulmonary metastases of rectal cancer were considered to result in clinical complete response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularChemoembolization, TherapeuticLiver NeoplasmsLung NeoplasmsRectal NeoplasmsAntibodies, Monoclonal, HumanizedHumansBevacizumabPortal VeinMicrosatellite Repeats

Stichwörter der Autor:innen

Atezolizumab plus bevacizumabMetastatic colorectal cancerUnresectable hepatocellular carcinoma

Substanzen

atezolizumabBevacizumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Diagnostic and Interventional Radiology, Aichi Cancer Center Hospital, 1-1, Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan. 105824@aichi-cc.jp.
  • Department of Diagnostic and Interventional Radiology, Aichi Cancer Center Hospital, 1-1, Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.
  • Department of Radiology, Shiga University of Medical Science, Otsu, Shiga, Japan.

Zitieren

APA

Inaba, Y., Chatani, S., Murata, S., Sato, Y., Imamine, R., Kato, M., Onaya, H., & Yamaura, H. (2024). Treatment of hepatocellular carcinoma with a portal vein tumor thrombus and pulmonary metastases of rectal cancer with microsatellite stability using atezolizumab plus bevacizumab. Clinical Journal of Gastroenterology. https://doi.org/10.1007/s12328-024-01921-2

Vancouver

Inaba Y, Chatani S, Murata S, Sato Y, Imamine R, Kato M, et al. Treatment of hepatocellular carcinoma with a portal vein tumor thrombus and pulmonary metastases of rectal cancer with microsatellite stability using atezolizumab plus bevacizumab. Clinical Journal of Gastroenterology. 2024. doi:10.1007/s12328-024-01921-2

BibTeX
@article{Inaba2024,
  author = {Inaba, Yoshitaka and Chatani, Shohei and Murata, Shinichi and Sato, Yozo and Imamine, Rinpei and Kato, Mina and Onaya, Hiroaki and Yamaura, Hidekazu},
  title = {Treatment of hepatocellular carcinoma with a portal vein tumor thrombus and pulmonary metastases of rectal cancer with microsatellite stability using atezolizumab plus bevacizumab},
  journal = {Clinical Journal of Gastroenterology},
  year = {2024},
  doi = {10.1007/s12328-024-01921-2}
}
Kostenlos starten →